Ephedra sinica

? Ephedra {{{status}}} Fossil range: {{{fossil_range}}}
Ephedra sinica
Plant Info
Common name(s): {{{common_names}}} Growth habit: {{{growth_habit}}} Height: ⇕ {{{high}}} Width: ⇔ {{{wide}}} Lifespan: ⌛ {{{lifespan}}} Exposure: ☼ {{{exposure}}} Water: ☂ {{{water}}} Features: ❀ {{{features}}} Poisonous: ☠ {{{poisonous}}} Hardiness: ❆ {{{hardiness}}} USDA Zones: {{{usda_zones}}} Sunset Zones: {{{sunset_zones}}}
Scientific classification
Domain: {{{domain}}} Superkingdom: {{{superregnum}}} Kingdom: Plantae Subkingdom: {{{subregnum}}} Superdivision: {{{superdivisio}}} Superphylum: {{{superphylum}}} Division: Gnetophyta Phylum: {{{phylum}}} Subdivision: {{{subdivisio}}} Subphylum: {{{subphylum}}} Infraphylum: {{{infraphylum}}} Microphylum: {{{microphylum}}} Nanophylum: {{{nanophylum}}} Superclass: {{{superclassis}}} Class: Gnetopsida Sublass: {{{subclassis}}} Infraclass: {{{infraclassis}}} Superorder: {{{superordo}}} Order: Ephedrales Suborder: {{{subordo}}} Infraorder: {{{infraordo}}} Superfamily: {{{superfamilia}}} Family: Ephedraceae Subfamily: {{{subfamilia}}} Supertribe: {{{supertribus}}} Tribe: {{{tribus}}} Subtribe: {{{subtribus}}} Genus: Ephedra L. Subgenus: {{{subgenus}}} Section: {{{sectio}}} Series: {{{series}}} Species: E. sinica Subspecies: {{{subspecies}}}
[[{{{diversity_link}}}|Diversity]]
{{{diversity}}}
Binomial name
Ephedra sinica
Trinomial name
{{{trinomial}}}
Type Species
{{{type_species}}}
{{{subdivision_ranks}}}
[[Image:{{{range_map}}}|{{{range_map_width}}}|]]
Synonyms
{{{synonyms}}}

Ephedra sinica is a member of the ephedraceae family, native to China. It is also known as "Chinese Ephedra", Ma Huang, and "ephedra".

Ethnomedical uses

• Dried aerial parts are used to treat asthma, allergic rhinitis, upper respiratory infection, colds, and as a general stimulant.

Legality

As of April 21^st, 2006, the FDA's decision to ban nutritional/diet supplements from containing the plant or extracts thereof of ephedra was upheld by the Tenth Circuit courts.

U.S. federal congress is currently discussing the scheduling of pseudoephedrine into Schedule V. Jan 2005. The bill created in Congress is S 103, Jan 24, 2005.

References

• http://www.mayoclinic.com/health/ephedra/NS_patient-ephedra
• http://www.fda.gov/oc/initiatives/ephedra/february2004/
• http://www.hsph.harvard.edu/Organizations/DDIL/ephedrine.html
• http://data.opi.state.mt.us/bills/mca/50/32/50-32-229.htm

See Also

• Ephedrine